PL Valuation
Planet Labs PBC
$
3.830
- Overview
- Forecast
- Valuation
PL Relative Valuation
PL's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, PL is overvalued; if below, it's undervalued.
Historical Valuation
No Data
Competitors Valuation Multiple
The average P/S ratio for PL's competitors is 3.18, providing a benchmark for relative valuation. Planet Labs PBC Corp (PL) exhibits a P/S ratio of 4.35, which is 36.74% above the industry average. Given its robust revenue growth of 4.59%, this premium appears unsustainable.
People Also Watch
DGII
Digi International Inc
33.300
USD
+0.03%
PUMP
ProPetro Holding Corp
5.680
USD
-2.24%
FBMS
First Bancshares Inc (Mississippi)
0
USD
+0.47%
SNDX
Syndax Pharmaceuticals Inc
9.300
USD
+2.76%
OMI
Owens & Minor Inc
7.090
USD
-3.93%
MYGN
Myriad Genetics Inc
4.430
USD
+7.26%
DAVE
Dave Inc
182.970
USD
-1.34%
TLRY
Tilray Brands Inc
0.453
USD
-8.48%
BCSF
Bain Capital Specialty Finance Inc
15.750
USD
+0.45%
LX
Lexinfintech Holdings Ltd
8.890
USD
+1.83%
FAQ
Is Planet Labs PBC (PL) currently overvalued or undervalued?
Planet Labs PBC (PL) is now in the Fair zone, suggesting that its current forward PS ratio of 4.35 is considered Fairly compared with the five-year average of 4.49. The fair price of Planet Labs PBC (PL) is between 2.29 to 5.33 according to relative valuation methord.
What is Planet Labs PBC (PL) fair value?
How does PL's valuation metrics compare to the industry average?
What is the current P/B ratio for Planet Labs PBC (PL) as of May 20 2025?
What is the current FCF Yield for Planet Labs PBC (PL) as of May 20 2025?
What is the current Forward P/E ratio for Planet Labs PBC (PL) as of May 20 2025?